The COVID-19 pandemic was a worldwide outbreak of coronavirus disease 2019 (COVID-19), an illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus first identified in Wuhan, China, in late 2019. It spread to nearly every country, caused millions of deaths, disrupted economies and everyday life, and accelerated the development of new vaccine platforms. The World Health Organization (WHO) ended its emergency designation in 2023, but the virus continued to circulate.
Background and naming
SARS-CoV-2 is an RNA virus related to the coronavirus behind the 2002–2003 SARS outbreak. Infection could produce no noticeable illness or a fatal course, with fever, sore throat, nocturnal cough, and fatigue among the most frequent complaints. Severe cases involved pneumonia, respiratory failure and damage to multiple organs, and a subset of patients developed persistent symptoms often called long COVID. The disease was named COVID-19 by the WHO in February 2020.
Emergence and early spread
Clusters of pneumonia cases of unknown cause were reported in Wuhan in December 2019. Within weeks the virus had moved across borders through air travel; the first case outside China was recorded in Thailand in mid-January 2020. Early responses in many countries included travel restrictions, quarantine of travellers, mass testing campaigns and, in the most affected regions, lockdowns that closed workplaces, schools and borders. The speed and scale of transmission, including spread by people without symptoms, made containment difficult.
International declarations and timeline
The WHO classified the outbreak as a public health emergency of international concern (PHEIC) on 30 January 2020, and its characterization as a pandemic followed on 11 March 2020. Vaccines were authorized for emergency use within about a year of the first declaration, and mass vaccination began in late 2020 and 2021.
On 5 May 2023, WHO Director-General Tedros Adhanom Ghebreyesus announced the end of the emergency. He pointed to a downward trend, with population immunity increasing from vaccination and infection, mortality decreasing and the pressure on health systems easing. The Emergency Committee had concluded that the criterion of an extraordinary event was no longer met. The United States' domestic emergency declaration ended on 11 May 2023.
The end of the emergency did not settle the question of the disease's status. Experts were uncertain as of 2024 whether COVID-19 was still a pandemic or had become endemic, and the virus was expected to keep circulating indefinitely.
Epidemiology and mortality
Official death counts are generally regarded as undercounts, particularly in countries with limited testing or incomplete civil registration. A 2022 analysis in The Lancet reported 5.94 million COVID-19 deaths recorded worldwide between 1 January 2020 and 31 December 2021, but estimated about 18.2 million excess deaths over the same period, with a 95% uncertainty interval of 17.1 to 19.6 million. Excess mortality is the difference between observed deaths from all causes and the number expected from prior trends. Independent modelling by The Economist gave a similar figure of about 18.0 million for a comparable period.
WHO's own excess-mortality analysis produced a lower central figure. Its estimate of roughly 14.8 million excess deaths for 2020–2021 was about 2.7 times the officially counted toll. Differences among these estimates arise from modelling choices, data gaps and how countries with missing records were handled. Excess mortality also varied widely across regions, with the highest rates in parts of Latin America, Eastern Europe and South Asia.
Transmission occurred in successive waves. Early strains were followed by the Alpha and Delta variants, and then by the Omicron lineage and its descendants from late 2021. Later variants were generally more transmissible, although severity tended to fall, partly because of vaccination and prior infection.
Origin debate
The origin of SARS-CoV-2 remains disputed. Two main hypotheses have been advanced. The zoonotic hypothesis holds that the virus originated naturally from an animal-to-human spillover event followed by sustained human-to-human transmission. The Huanan Seafood Wholesale Market in Wuhan is the most frequently proposed site for such a spillover. The laboratory hypothesis holds that researchers constructed or simply cultured SARS-CoV-2 during research on bat-origin coronaviruses and that an accidental exposure began the pandemic.
Neither hypothesis has been conclusively confirmed. A 2025 review found that current evidence does not conclusively support either a natural zoonotic spillover or a research-related laboratory incident. Beijing has denied that the Wuhan Institute of Virology conducted the relevant work, and critics have pointed to limited transparency and access to early data. Government positions have also been divided. As of early 2023, U.S. intelligence agencies were split, with four of the eight intelligence agencies leaning toward a natural origin with low confidence, while the Department of Energy and the Federal Bureau of Investigation supported a lab origin.
Public health responses and countermeasures
Non-pharmaceutical interventions included mask wearing, physical distancing, limits on gatherings, travel controls, and case isolation with contact tracing. Their effectiveness and their economic and social costs became a major subject of debate.
Diagnosis relied heavily on reverse-transcription PCR tests, and genome sequencing of viral samples allowed the tracking of variants through public health surveillance networks.
Several vaccine platforms were used, including mRNA vaccines, viral-vector vaccines, inactivated virus vaccines and protein subunit vaccines. The speed of development was unusually rapid, which reflected prior research on coronaviruses, large-scale government funding and parallel trial and manufacturing processes. A modelling study published in The Lancet Infectious Diseases estimated that, in the first year of rollout, vaccination averted between 14.4 and 19.8 million deaths. Vaccine supply and distribution were uneven between high-income and low-income countries.
Therapeutic research tested antivirals, corticosteroids, monoclonal antibodies and anticoagulants. Large randomized controlled trials identified some treatments that reduced mortality among hospitalized patients, notably corticosteroids for severe disease, while others showed little benefit.
Social and economic impact
The pandemic produced the sharpest global economic contraction in decades in 2020, followed by uneven recovery and high inflation in many countries. Lockdowns and restrictions affected the labor market, pushed commerce toward online platforms (e-commerce), and interrupted supply chains. Schools were closed for extended periods in many countries, with lasting effects on learning. Health systems in several regions were overwhelmed, and the disruption of routine care for other conditions caused additional deaths. Rates of anxiety and depression rose in many populations, and the burdens fell unevenly, affecting older adults, essential workers, and disadvantaged communities most severely.
Legacy and continuing debates
Analyses of the pandemic have focused on preparedness, including surveillance, stockpiling, the design of international health regulations, and equitable access to medical countermeasures. Debate continues over the balance between public health restrictions and civil liberties, the effects of school closures and lockdowns, the handling of early information, and the origin question. The pandemic also left a substantial body of data on immunity, long-term health effects and the performance of mRNA technology that continues to be studied.
References
- COVID-19 pandemicen.wikipedia.org
- Covid ‘emergency is over’: 20 key moments of pandemic that changed the worldirishtimes.com
- WHO ends the COVID-19 public health emergency - PMC - NIHpmc.ncbi.nlm.nih.gov
- Timeline of the COVID-19 pandemic in 2023en.wikipedia.org
- Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21healthdata.org
- A Critical Analysis of the Evidence for the SARS-CoV-2 Origin Hypothesesjournals.asm.org
- Current Debate Regarding Laboratory and Natural Origin Hypotheses of SARS-CoV-2: A Critically Balanced Reviewintechopen.com
- What does the science say about the origin of the SARS-CoV-2 pandemic?npr.org
- WHO chief declares end to COVID-19 as a global health emergencynews.un.org
- WHO: COVID-19 no longer a global public health emergencymedicalnewstoday.com
- The WHO estimates of excess mortality associated with the COVID-19 pandemic - PubMedpubmed.ncbi.nlm.nih.gov
- The WHO estimates of excess mortality associated with the COVID-19 pandemicnature.com
- The Origins of Covid-19 — Why It Matters (and Why It Doesn’t)nejm.org